Although these signatures were excluded from this study, these may be important because TGFβ and LEF1 signatures are involved in epithelial‐to‐mesenchymal transition (EMT) and NFκB and RELA signatures are involved in tumor immunity (Figure S1C). The gene discussed is NFKB1; the disease is neoplasm.